alexa
Reach Us +3225889658
Matthew D Reed | OMICS International
ISSN: 2155-9872

Journal of Analytical & Bioanalytical Techniques
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Recommended Conferences
Share This Page

Matthew D Reed

Director of Preclinical Drug Development, Applied Life Sciences and Toxicology, Lovelace Respiratory Research Institute, Albuquerque, NM

Biography

2007 - Present Director of Preclinical Drug Development, Applied Life Sciences and Toxicology, Lovelace Respiratory Research Institute, Albuquerque, NM
2007 - Present Scientist, Lovelace Respiratory Research Institute, Albuquerque, NM
2000 - 2007 Associate Scientist, Lovelace Respiratory Research Institute, Albuquerque, NM
2000 - Present Clinical Assistant Professor, University of New Mexico College of Pharmacy, Albuquerque, NM
1999 - 2000 Senior Scientist/Toxicologist, Alcon Research, Ltd., Ft. Worth, TX
1998 - 1999 Postdoctoral Fellow, University of New Mexico College of Pharmacy, Toxicology Program, Albuquerque, NM
1997 - 1998 Postdoctoral Fellow, University of Texas M. D. Anderson Cancer Center, Science Park Research Division
1992 - 1997

Graduate Studies, Dept. Medical Pharmacology/Toxicology, Texas A&M University, College Station, TX

Research Interest

Dr. Reed also serves as study director for contract sponsored FDA and EPA regulatory toxicology studies. Dr. Reed's basic science interests include the toxicology of inhaled toxicants and chemical and biochemical toxicology.

Global Speakers in the subject

Global Experts in the subject

Top